The COVID-19 MS Coalition-accelerating diagnostics, prognostics, and treatment

Affiliations

• ¹ Department of Chemistry and Oxford Glycobiology Institute, Department of Biochemistry, University of Oxford, Oxford, UK.
• ² Centre for Proteome Research, Institute for Integrative Biology and Department of Biochemistry, University of Liverpool, Liverpool, UK.
• ³ Department of Chemistry and Surrey Ion Beam Centre, University of Surrey, Surrey, UK.
• ⁴ Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
• ⁵ Department of Pharmaceutical Chemistry & Bioanalytics, Institute of Pharmacy, Charles Tanford Protein Center, Martin-Luther University Halle-Wittenberg, Halle, Germany.
• ⁶ Proteomics Unit, Centro Nacional de Biotecnología, Madrid, Spain; ProteoRed-ISCIII, Madrid, Spain.
• ⁷ Institute of Structural and Molecular Biology, Department of Structural and Molecular Biology, University College London, London, UK.
• ⁸ National Measurement Laboratory, LGC, Teddington, Middlesex, UK.
• ⁹ Division of Infection, Immunity and Respiratory Medicine, Manchester Academic Health Science Centre, Manchester, UK; Michael Barber Centre for Collaborative Mass Spectrometry, Manchester Institute of Biotechnology, University of Manchester, Manchester M1 7DN, UK.
• ¹⁰ Michael Barber Centre for Collaborative Mass Spectrometry, Manchester Institute of Biotechnology, University of Manchester, Manchester M1 7DN, UK; Department of Chemistry, University of Manchester, Manchester M1 7DN, UK. Electronic address: perdita.barran@manchester.ac.uk.